BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Plebani M. Analytical quality: an unfinished journey. Clinical Chemistry and Laboratory Medicine (CCLM) 2018;56:357-9. [DOI: 10.1515/cclm-2017-0717] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
Number Citing Articles
1 Plebani M. Quality in laboratory medicine and the Journal: walking together. Clin Chem Lab Med 2022. [PMID: 35969689 DOI: 10.1515/cclm-2022-0755] [Reference Citation Analysis]
2 Wauthier L, Plebani M, Favresse J. Interferences in immunoassays: review and practical algorithm. Clin Chem Lab Med 2022. [PMID: 35304841 DOI: 10.1515/cclm-2021-1288] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
3 Zaninotto M, Plebani M. Understanding and managing interferences in clinical laboratory assays: the role of laboratory professionals. Clin Chem Lab Med 2020;58:350-6. [PMID: 31622245 DOI: 10.1515/cclm-2019-0898] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
4 Plebani M. Laboratory medicine in the COVID-19 era: six lessons for the future. Clin Chem Lab Med 2021. [PMID: 33826810 DOI: 10.1515/cclm-2021-0367] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
5 Aita A, Sciacovelli L, Plebani M. The silk road to total quality in Laboratory Medicine. Clin Chem Lab Med 2019;57:769-72. [PMID: 30982003 DOI: 10.1515/cclm-2019-0331] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Plebani M, Sciacovelli L, Bernardi D, Aita A, Antonelli G, Padoan A. What information on measurement uncertainty should be communicated to clinicians, and how? Lab sluzh 2019;8:44. [DOI: 10.17116/labs2019803144] [Reference Citation Analysis]
7 Zhou R, Wei Y, Sciacovelli L, Plebani M, Wang Q. A pilot study for establishing quality indicators in molecular diagnostics according to the IFCC WG-LEPS initiative: preliminary findings in China. Clinical Chemistry and Laboratory Medicine (CCLM) 2019;57:822-31. [DOI: 10.1515/cclm-2018-0966] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Clerico A, Belloni L, Carrozza C, Correale M, Dittadi R, Dotti C, Fortunato A, Vignati G, Zucchelli GC, Migliardi M; a document endorsed by the Italian Section of the European Ligand Assay Society (ELAS). A Black Swan in clinical laboratory practice: the analytical error due to interferences in immunoassay methods. Clin Chem Lab Med 2018;56:397-402. [PMID: 29220884 DOI: 10.1515/cclm-2017-0881] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
9 Lippi G, Plebani M. Diabetes alert dogs: a narrative critical overview. Clinical Chemistry and Laboratory Medicine (CCLM) 2019;57:452-8. [DOI: 10.1515/cclm-2018-0842] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
10 Plebani M. Clinical laboratory: bigger is not always better. Diagnosis 2018;5:41-6. [DOI: 10.1515/dx-2018-0019] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
11 Krouwer JS. Interferences, a neglected error source for clinical assays. Accred Qual Assur 2018;23:189-92. [DOI: 10.1007/s00769-018-1315-y] [Reference Citation Analysis]
12 Plebani M. Quality and future of clinical laboratories: the Vico’s whole cyclical theory of the recurring cycles. Clinical Chemistry and Laboratory Medicine (CCLM) 2018;56:901-8. [DOI: 10.1515/cclm-2018-0009] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]